Roche said its $4.3 billion takeover of Spark Therapeutics remained on track despite failing to get enough votes to clinch ...

A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

Millions of people living with arthritis may unknowingly be eating foods that increase inflammation, joint stiffness, and ...

Celebrities may have glam squads and access to the best doctors and treatments in the world — and yet even they have skin ...

If you’ve been told your joint pain is “just arthritis,” you may have also been told to slow down, take medication, and prepare for things to get worse. For many people over 40, that advice feels like ...

Osteoarthritis, far from being “simply wear and tear,” demands a multifaceted management strategy, according to a speaker at ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated C-reactive protein levels, may benefit from guselkumab plus golimumab therapy.